Official title and information are available only for Plus and Premium subscribers.
Patent Granted Synucleinopathies (also called α-Synucleinopathies) are neurodegenerative diseases characterised by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibres or glial cells.[1] One prevailing hypothesis has been that the death of dopaminergic cells is the proximate cause of functional deficits.
To see the additional information details please login and subscribe to a Plus or Premium account.
